Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Istradefylline adjunctive therapy for obsessive-compulsive disorder
jRCTs051250026Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Istradefylline in obsessive compulsive disorder (OCD), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Started Jul 2025; status: recruiting.
02
Drugs
Istradefylline
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on jRCTs051250026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051250026.